<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01815281</url>
  </required_header>
  <id_info>
    <org_study_id>GONDOLAPILOTA</org_study_id>
    <nct_id>NCT01815281</nct_id>
  </id_info>
  <brief_title>Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.</brief_title>
  <acronym>GONDOLAPILOTA</acronym>
  <official_title>Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaluate safety and effectiveness of Foot Mechanical
      stimulation to improving Gait and Gait Related Disorders in Parkinson Disease and Progressive
      Supranuclear Palsy both stable and with motor fluctuation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Timed Up and Go.</measure>
    <time_frame>Change from Baseline in Timed Up and Go test at 1 month follow up.</time_frame>
    <description>Time Up and Go test will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minuts walking test.</measure>
    <time_frame>Change from Baseline in gait speed at 1 month follow up</time_frame>
    <description>6 minuts walking test will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait Parameters</measure>
    <time_frame>Change from Baseline in Gait Parameters at 1 month follow up</time_frame>
    <description>Gait Analysis will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FREEZING OF GAIT QUESTIONNAIRES</measure>
    <time_frame>Change from Baseline in FREEZING OF GAIT QUESTIONNAIRES at 1 month follow up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>THE PARKINSON'S DISEASE QUESTIONNAIRE (PDQ-39)</measure>
    <time_frame>Change from Baseline in PDQ-39 at 1 month follow up</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>UNIFIED PARKINSON'S DISEASE RATING SCALE (UPDRS).</measure>
    <time_frame>Change from Baseline in UPDRS scores at 1 month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>PROGRESSIVE SUPRANUCLEAR PALSY RATING SCALE (PSP RATING SCALES)</measure>
    <time_frame>Change from Baseline in PSP RATING SCALES scores at 1 month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Functional Ambulation classification (FAC)</measure>
    <time_frame>Change from Baseline in FAC scores at 1 month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Walking handicap Scale (WHS)</measure>
    <time_frame>Change from Baseline in WHS scores at 1 month follow up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>BOLD signal response to gondola treatment</measure>
    <time_frame>Change from Baseline in UPDRS scores at 1 month follow up</time_frame>
    <description>BOLD signal will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Idiopathic Parkinson's Disease</condition>
  <condition>Progressive Supranuclear Palsy</condition>
  <arm_group>
    <arm_group_label>Foot Mechanical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The FMS stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Footh Mechanical Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foot Mechanical Stimulation (GONDOLA)</intervention_name>
    <arm_group_label>Foot Mechanical Stimulation</arm_group_label>
    <arm_group_label>Footh Mechanical Stimulation</arm_group_label>
    <other_name>GONDOLA equipment (Ecker Technologies Sagl, Switzerland).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of idiopathic PD or PSP by UK Brain Bank criteria,

          -  Able to walk 25 feet unassisted or with minimal assistance;

          -  On stable doses of Parkinson's medications for at least 2 weeks prior to study onset;

          -  Endurance sufficient to stand at least 20 minutes unassisted per patient report.

        Exclusion Criteria:

          -  Other significant neurological or orthopedic problems.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrizio Stocchi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>IRCCS San Raffaele Pisana Rome Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrizio Sale, MD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS San Raffaele Pisana Rome Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabrizio Stocchi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Raffaele Pisana Rome Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Raffaele Cassino</name>
      <address>
        <city>Cassino (FR)</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Francesca De Pandis, MD</last_name>
      <email>maria.depandis@sanraffaele.it</email>
    </contact>
    <investigator>
      <last_name>Maria Francesca De Pandis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrizio Sale, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Campus Biomedico of Rome</name>
      <address>
        <city>Rome</city>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlo Cosimo Quattrocchi, MD</last_name>
      <email>c.quattrocchi@unicampus.it</email>
    </contact>
    <investigator>
      <last_name>Carlo Cosimo Quattrocchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele Pisana</name>
      <address>
        <city>Rome</city>
        <zip>00163</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizio Sale, MD</last_name>
      <email>patrizio.sale@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Fabrizio Stocchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrizio Sale, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Vacca, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2013</study_first_submitted>
  <study_first_submitted_qc>March 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2013</study_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Patrizio Sale , MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Supranuclear Palsy, Progressive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

